Neuroinflammation and the role of epigenetic-based therapies for Huntington’s disease management: the new paradigm
Crossref DOI link: https://doi.org/10.1007/s10787-024-01477-0
Published Online: 2024-04-23
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Temgire, Pooja
Arthur, Richmond
Kumar, Puneet https://orcid.org/0000-0002-7978-1043
Text and Data Mining valid from 2024-04-23
Version of Record valid from 2024-04-23
Article History
Received: 20 June 2023
Accepted: 9 April 2024
First Online: 23 April 2024
Declarations
:
: There are no relevant financial or non-financial interests to disclose for the authors.
: Not applicable.